Brief: Ayala Pharmaceuticals And Biosight Enter Into Definitive Merger Agreement
27/07/2023 15:02
July 27 (Reuters) - Ayala Pharmaceuticals Inc ADXS.PK :
* AYALA PHARMACEUTICALS AND BIOSIGHT ENTER INTO DEFINITIVE
MERGER
AGREEMENT
* AYALA PHARMACEUTICALS INC - ENTERED INTO A DEFINITIVE
MERGER
AGREEMENT PURSUANT TO WHICH AYALA WILL COMBINE WITH BIOSIGHT IN
AN ALL-STOCK TRANSACTION
Source text for Eikon: ID:nGNX4qLyJR
Further company coverage: ADXS.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ayala Pharmaceuticals
See all newsBrief: Ayala Pharmaceuticals Completes Sale Of AL102 To Immunome
Immunome slides on $200 mln equity offering
Immunome edges up after $200 mln equity offering
Brief: Immunome To Acquire AL102 Phase 3 Asset for the Treatment of Desmoid Tumors From Ayala Pharmaceuticals
Brief: Ayala Pharmaceuticals Announces AL102 Receives Orphan Drug Designation for Desmoid Tumors